Helen M. Thackray, Chief R&D Officer: Biocryst Pharmaceuticals BCRX Sell · Filed 23/04/05

Trade details

Type: Insider sale
Amount: $58,030
Shares · price: 7,000 sh · $8.29 a share
Held after: 207,275 sh
Stock: Biocryst Pharmaceuticals BCRX
Person: Helen M. ThackrayChief R&D Officer
Trade date: 23/04/03
Filed: 23/04/05
Days to filing: 2 days

Sold 3.3% of holdings

Share of holding sold: 3.3%

Biocryst Pharmaceuticals trades, last 26 weeks

What else happened in Biocryst Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/03/04~23/05/03

Helen M. Thackray's recent trades

Helen M. ThackrayChief R&D Officer
Planned saleBiocryst Pharmaceuticals
Planned sale
Biocryst Pharmaceuticals
BCRX
$328K
48,229 sh
$328K
Filed 25/11/25
Traded 25/11/25
Helen M. ThackrayChief R&D Officer
Planned saleBiocryst Pharmaceuticals
Planned sale
Biocryst Pharmaceuticals
BCRX
$307.7K
43,275 sh
$307.7K
Filed 25/11/21
Traded 25/11/21
Helen M. ThackrayChief R&D Officer
BuyBiocryst Pharmaceuticals
Buy
Biocryst Pharmaceuticals
BCRX
$175.8K
30,000 sh
$175.8K
Filed 24/05/15
Traded 24/05/14

Helen M. Thackray, Chief Officer — sold $58K of Biocryst Pharmaceuticals BCRX · 3.3% of holdings · 10b5-1 plan | Whalegun